In vitro experiments were performed using the same amount of cells derived from myometrium and leiomyoma [55]

In vitro experiments were performed using the same amount of cells derived from myometrium and leiomyoma [55]. shorter doubling time and a significantly higher expression of stemness genes ( 0.05), and (iii) LPCs secreted significantly higher levels ( 0.05) of cytokines related to chronic inflammation and significantly lower amounts ( 0.05) of cytokines related to acute inflammation. Despite the limited sample size, comparisons between leiomyoma and normal myometrium tissue from each patient allowed normalization of patient-specific differences. The evidenced cytokine expression pattern related to chronic inflammation in LPCs may play a role in the increased risk of adverse obstetric outcomes (infertility, spontaneous miscarriage, and preterm birth) in women affected by leiomyomas. These women should be recognized as high risk and subjected to specialized management both before and during pregnancy. 1. Introduction Uterine leiomyomas (fibroids) are benign tumors originating from the myometrium and the most common neoplasms of the female reproductive system [1, 2]. They cause prolonged bleeding, pelvic pain, recurrent abortions, and adverse obstetric outcomes and are a significant cause of infertility A939572 [3C5]. Their origin and pathophysiology are unclear. A wide range of factors, from genetic aberrations [6] to an undifferentiated cell population that A939572 could give rise to them [7, 8], has been investigated. The latter hypothesis is supported by the uterine tissue remodeling that occurs during life in physiological [9] and pathological conditions [10]. One possible explanation for the development of leiomyomas is the dysregulation of mesenchymal stem cell activity [9]. Previous studies [11, 12] have proposed that undifferentiated cells are involved in myometrial pathologies, and also leiomyoma onset may be the result of impaired function, proliferation, and differentiation of undifferentiated cells inside the myometrium that are under the effect of ovarian hormones [13, 14]. Moreover, the clonality of leiomyomas that originate from a single altered cell strongly enforces this hypothesis [1, 15, 16]. Undifferentiated cells have been sought in normal myometrium and leiomyoma tissue by a variety of techniques to address different questions [17C20]. A role for the microenvironment has been suggested for many tumor types, including leiomyoma [21C24], with inflammation appearing to exert a major effect. If the condition causing acute inflammation is not resolved, the inflammation may become chronic, A939572 favoring tumor onset and development. Chronic inflammation is maintained by cytokines secreted by the immune system as well as undifferentiated cells [25C29], which are involved in a complex crosstalk with neoplastic cells. These cytokines influence proliferation, fibrosis, and angiogenesis, which in turn sustain fibroid formation and growth [30C32]. Considering that (i) the existence of undifferentiated cells may correlate with leiomyoma onset, (ii) inflammation may sustain leiomyomas, and (iii) cytokines secreted by undifferentiated cells create an inflammatory microenvironment, this study was performed to isolate and characterize undifferentiated cells from myometrium (myometrial progenitor cells, MPCs) and from leiomyoma tissue (leiomyoma progenitor cells, LPCs) and to evaluate the expression of selected inflammation-related cytokines. In addition, the expression of MDR1 (a member of ABC family recognized as a stem cell marker) and of is culture time in hours [33]. 2.5. Rabbit Polyclonal to VAV1 (phospho-Tyr174) Characterization of Leiomyoma Progenitor Cells and Myometrium Progenitor Cells Cells were characterized by testing plastic adherence [34]. Immunophenotype and multipotency were evaluated as previously described [27]. Briefly, for immunophenotyping, 2.5??105 cells were stained for 45?min with fluorescein isothiocyanate- (FITC-) conjugated antibodies (Becton Dickinson) against HLA-DR, CD14, CD19, CD34, CD45, CD73, CD90, CD105 OCT4, SOX2, NANOG, and KLF4. Since it is reported [35] that many of the mesenchymal markers are also found in fibroblasts, we analyzed the level of CD9 (Becton Dickinson), which is differently expressed by the two cellular subsets. For differentiation assay, cells were induced towards A939572 osteocytes, chondrocytes, and adipocytes using STEMPRO? Osteogenesis and Chondrogenesis and Adipogenesis Kits (GIBCO, Invitrogen), respectively. Osteogenic differentiation was assessed by von Kossa and alkaline phosphatase (ALP) stainings; adipogenic differentiation was tested by Oil Red staining; for chondrogenesis, cells were cultured in pellet culture system and the sections were exposed to a solution of Safranin-O. Cells cultured in MSCGM alone were used as negative controls. The expression of stemness genes was analyzed by real-time PCR (RT-PCR) and cytofluorometry as above reported; total RNA was isolated from 1??106 cells at passage 4th by using 5 PRIME PerfectPure RNA Purification (5 PRIME, Hamburg, Germany) and retrotranscribed in cDNA (GoScript? Reverse Transcription System, Promega, Italy). A939572 All samples were tested in triplicate with the housekeeping genes RPLP0 and GAPDH for data.